Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records)
|Query Trace: Disease Progression and meta-analysis and EGFR[original query]|
| Combination of EGFR-TKIs and chemotherapy as first-line therapy for advanced NSCLC: a meta-analysis.
PloS one 2013 8 (11): e79000.
OuYang Pu-Yun, Su Zhen, Mao Yan-Ping, Deng Wuguo, Xie Fang-Y
| Anti-epidermal growth factor receptor monoclonal antibody-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of PIK3CA mutations in KRAS wild-type patients.
Archives of medical science : AMS 2014 Feb 10 (1): 1-9.
Huang Lulu, Liu Zhenfang, Deng Donghong, Tan Aihua, Liao Ming, Mo Zengnan, Yang Xiao
| Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival.
Journal of the National Cancer Institute 2017 Jun 109 (6): .
Lee Chee Khoon, Davies Lucy, Wu Yi-Long, Mitsudomi Tetsuya, Inoue Akira, Rosell Rafael, Zhou Caicun, Nakagawa Kazuhiko, Thongprasert Sumitra, Fukuoka Masahiro, Lord Sally, Marschner Ian, Tu Yu-Kang, Gralla Richard J, Gebski Val, Mok Tony, Yang James Chih-Hs
| A meta-analysis of the comparing of the first-generation and next-generation TKIs in the treatment of NSCLC.
Mathematical biosciences and engineering : MBE 2019 9 16 (5): 5687-5696.
Li Yong Xing, Yang Jian Ye, Xu Yu Fen, Zhang Ming, Zhang Xiao Ping, Chen Wen Yu, Lv Xiao Do
| The impact of epidermal growth factor receptor mutations on the efficacy of definitive chemoradiotherapy in patients with locally advanced unresectable stage III non-small cell lung cancer: a systematic review and meta-analysis.
Expert review of anticancer therapy 2019 May .
Qin Qin, Peng Bing, Li Baoshe
| Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis.
Cancer medicine 2019 Dec .
Bylsma Lauren C, Gillezeau Christina, Garawin Tamer A, Kelsh Michael A, Fryzek Jon P, Sangaré Laura, Lowe Kimberly
| Plasma ctDNA RAS status selects patients for anti-EGFR treatment rechallenge in metastatic colorectal cancer: a meta-analysis.
Experimental oncology 2021 09 43 (3): 252-256.
Vlachou M S, Mauri D, Zarkavelis G, Ntellas P, Tagkas C, Gkoura S, Pentheroudakis
| Rational Application of First-Line EGFR-TKIs Combined with Antiangiogenic Inhibitors in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
BioMed research international 2021 8850256.
Ma Jie-Tao, Guo Yi-Jia, Song Jun, Sun Li, Zhang Shu-Ling, Huang Le-Tian, Jing Wei, Zhao Jian-Zhu, Han Cheng-
| Should We Perform Repeated Re-Biopsy for the Detection of T790M Mutation?
Cancer research and treatment 2023 4 .
Saerom Kim, Soo Han Kim, Jinmi Kim, Mi-Hyun Kim, Min Ki Lee, Jung Seop E
- Page last reviewed:Feb 1, 2023
- Page last updated:May 22, 2023
- Content source: